| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Dorval Allison | Director | C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES | /s/ Gordon Esplin as attorney-in-fact for Allison Dorval | 13 Jun 2025 | 0001625110 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PBYI | Common Stock | Award | $0 | +27,000 | +45% | $0 | 87,000 | 11 Jun 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer. |